CCO Infectious Disease Podcast
Weekly updates on new data and best practices in patient care for a variety of infectious diseases including COVID-19, HIV, and viral hepatitis, from Clinical Care Options. Gain practical strategies and earn CME/CE credit for selected episodes.
- Update frequency
- every 3 days
- Average duration
- 25 minutes
- Episodes
- 461
- Years Active
- 2020 - 2025
Key Decisions in HIV Care: ART Considerations in the Inpatient Setting
In this episode, Jason Schafer, PharmD, MPH, explores recommendations and data on managing antiretroviral therapy (ART) in the inpatient setting.
Listen as he gives his perspectives on:
- Antiretroviral …
Monitoring and Treating Patients Coinfected With HBV and HDV
Hepatitis delta virus (HDV) only exists in patients with hepatitis B virus (HBV) coinfection. In part 1 of this 2-part podcast series, hear Heiner Wedemeyer, MD, and Cihan Yurdaydin, MD, discuss thei…
Starting HBV Treatment in Pregnancy: Conversations Between Patient and Physician #3
Episode 3 of this series features Anna Cristina L. dela Cruz, MD, in conversation with patient Melody Cheng about Melody’s decision to start hepatitis B virus (HBV) antiviral therapy during pregnancy…
Hepatitis Delta Treatment: Where We Are and Where We Are Headed
Treatment options for hepatitis delta virus (HDV) are lacking, but many exciting agents are under investigation. Hear Drs Nancy Reau and Stefan Zeuzem discuss their thoughts on up-and-coming agents f…
How Can We Destigmatize a Hepatitis B Diagnosis? Conversations Between Patient and Physician #2
In episode 2 of this series, tune in to a conversation between Robert G. Gish, MD, and patient advocate Jacki Chen, PhD, about the potential benefits of simplifying our approach to treating patients …
Lessons From Lockdown: Caring for Patients With Hepatitis B Virus Infection in the COVID-19 Era—Audio Recap
In this episode, Drs Norah Terrault, MD, MPH, and Grace LH Wong, MD, share lessons learned in the care of patients with hepatitis B virus (HBV) in the COVID-19 era, including:
- HBV cascade of care befo…
COVID-19: Omicron Transmissibility, Severity, and Vaccine Effectiveness
In this episode, Sharon R. Lewin, AO, FRACP, PhD, FAHMS, discusses what is known about the SARS-CoV-2 omicron variant, including:
Transmissibility and infectiousness
- Immune evasion
Disease severity
- Ris…
Importance of Treatment for HBV: Patient and Physician Sharing Session #6
In episode 6 of an ongoing series of sharing sessions between a physician and patient, Tarik Asselah, MD, PhD, and his patient, who is living with chronic hepatitis B (CHB), discuss:
- Importance and go…
Key Decisions in HIV Care: Treating HIV/HCV Coinfection
In this episode, Mark S. Sulkowski, MD, explores recommendations and data on treating HIV and hepatitis C virus (HCV) in patients who are coinfected.
Listen as he gives his perspectives on:
- Prioritizat…
My Management Strategies for NASH in Patients With HIV
In this episode, Mark S. Sulkowski, MD, discusses his recommended approach for managing nonalcoholic steatohepatitis in patients with HIV, including recognizing nonalcoholic steatohepatitis, recommen…
Lessons From Lockdown: Hepatitis Delta Elimination Strategies in the COVID-19 Era
In this episode, Robert G. Gish, MD, and Pietro Lampertico, MD, PhD, share lessons learned in the care of patients coinfected with hepatitis B virus and hepatitis delta virus (HDV), including:
- Burden …
Key Decisions in HIV Care: Renal and Hepatic Considerations in Older PWH
In this episode from the series “Key Decisions in HIV Care,” Jonathan Appelbaum, MD, FACP, AAHIVS, and Jens D. Lundgren, MD, DMSc, discuss important considerations for antiretroviral therapy (ART) us…
Don’t Forget About the Liver! NASH in Patients with HIV: Answering the Questions Forum
In this episode, Jürgen K. Rockstroh, MD, and Giada Sebastiani, MD, discuss key strategies to appropriately screen for, identify, and manage nonalcoholic steatohepatitis in persons with HIV. They als…
NASH in PWH: Key Strategies for Screening and Identification
In this episode, Jürgen K. Rockstroh, MD, discusses his recommended approach for diagnosing nonalcoholic steatohepatitis in patients with HIV, the value of noninvasive diagnostic tests such as serum …
Key Decisions in HIV Care: Considering the Use of Proviral DNA Genotyping to Inform ART Choice
In this episode, John D. Baxter, MD, explores recommendations and data on the use of proviral DNA genotyping to inform antiretroviral therapy (ART) choice for patients who are treatment experienced.
L…
Tackling Racial Inequities in HIV Care Globally
In this episode, Rageshri Dhairyawan, MBBS, BSc, FRCP, DipGUM, DFSRH, DipHIV, and Solange L. Baptiste, ScM, discuss the burden of HIV among BIPOC and migrant communities and key strategies to reduce …
Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance
In this episode, John D. Baxter, MD, explores recommendations and data on choosing antiretroviral therapy with transmitted drug resistance. Listen as he gives his perspectives on:
|
Omicron Variant: Effects on Treatments for COVID-19
The SARS-CoV-2 omicron variant has affected which of our COVID-19 treatment strategies are currently effective, with some expected to maintain their efficacy and some expected to lose their efficacy.…
Tackling Racial Inequities in HIV Care in the United States
In this episode, Samantha V. Hill, MD, MPH, and David Malebranche, MD, MPH, examine key facilitators to tackling racial inequities in HIV care, including:
- Barriers to HIV testing, prevention, and trea…
Key Decisions in HIV Care: ART Considerations With Coinfections
In this episode from the series “Key Decisions in HIV Care,” Daria Podlekareva, MD, PhD, and Mark S. Sulkowski, MD, discuss important considerations for ART use in patients with coinfections, includi…